Affects of Echinococcus multilocularis metacestode infection on the natural killer T cells and their subsets in mouse spleen

doi:10.12140/j.issn.1000-7423.2021.03.004

Abstract

Abstract:

Objective To understand the affects of Echinococcus multilocularismetacestode infection to natural killer T (NKT) cells and their subsets in mouse spleen. Methods Twenty-four C57BL/6 mice were randomly assigned into low, medium, high infection groups and control group (6 mice in each). The mice in low, medium, high infection groups were infected with 50, 500, 2 000 protoscoleces, respectively, through hepatic portal vein, while the mice in the control group injected with the same amount of saline. Two weeks after infection, the mice liver and spleen were collected to prepare liver tissue slices. The slices were stained with Masson routine method to observe the metacestodes lesion and liver fibrosis. Spleen lymphocyte suspensions were prepared for examining different NKT subsets, and the secreted cytokines by using flow cytometry.Results Two weeks after infection, there was no significant change in the mice liver of the control group. In the low and medium infection groups, only a small amount of granulomas were seen in the liver, together with weak inflammatory response which showed a conversion toward fibrosis repair; however, in the high infection group, a small germinal layer structure was formed in the liver, surrounded by dense inflammatory cells. The absolute numbers of splenic NKT cells in the medium and high infection groups were (6.32 ± 0.53) × 10 ⁵ and (7.37 ± 1.72) × 10⁵, respectively, which were higher than those in the control group and the low infection group [(5.02 ± 1.08) × 10 ⁵ and (4.90 ± 1.27) × 10 ⁵, P < 0.01]. The proportions of splenic NKT1-type cells secreting IFN-γ in the medium and high infection groups were (13.93 ± 1.61)% and (10.9 ± 3.04)%, respectively, which were lower than those in the control group and the low infection group [(17.3 ± 3.18)% and (19.42 ± 2.82)%, P < 0.01)]; the proportions of splenic NKT2-type cells secreting IL-4 in the low, medium and high infection groups were (5.62 ± 0.58)%, (5.86 ± 1.43)% and (5.92 ± 0.94)%, respectively, which were higher than that in the control group [(4.37 ± 0.83) %, P < 0.05)]; the proportion of splenic NKT17-type cells secreting IL-17A in the low and medium infection groups were (7.02 ± 1.19)% and (6.62 ± 0.41)%, respectively, which were higher than those in the control group and the high infection group [(4.68 ± 0.73)% and (3.73 ± 1.04)%, P < 0.01]. The absolute numbers of splenic CD4 ⁺ NKT cells in the medium and high infection groups were (1.75 ± 0.36) × 10 ⁵ and (1.82 ± 0.24) × 10 ⁵, respectively, which were higher than those in the control group [(1.24 ± 0.26) × 10 ⁵, P < 0.01]; the proportions of splenic CD4 ⁺ NKT1-type cells secreting IFN-γ in the low, medium- and high infection groups were (19.42 ± 2.82)%, (14.40 ± 1.81)%, and (12.5 ± 2.96)%, respectively, which were lower than those in the control group [(21.16 ± 2.83) %,P < 0.01]; the proportions of splenic CD4 ⁺ NKT17-type cells secreting IL-17A in the low, medium and high infection groups were (18.73 ± 1.99)%, (16.06 ± 1.42)% and (14.41 ± 3.55)%, respectively, which were higher than that in the control group [(10.27 ± 1.79)%,P < 0.01]. The proportions of splenic CD8 ⁺ NKT cells secreting IFN-γ in the low, medium and high infection groups were (10.04 ± 0.92)%, (13.43 ± 0.92)% and (9.24 ± 1.37)%, respectively, which were lower than those in the control group [(15.83 ± 1.59)%,P < 0.01]; the proportions of splenic CD8 ⁺ NKT cells secreting IL-10 in the medium and high infection groups were (4.07 ± 0.48)% and (3.92 ± 0.75)%, respectively, which were higher than that in the control group [(2.85 ± 0.64) %, P < 0.05]. The proportions of splenic DN NKT cells secreting IFN-γ in the medium and high infection groups were (17.48 ± 2.50)% and (14.06 ± 3.95)%, respectively, which were lower than that in the control group [(25.18 ± 5.78)%, P < 0.01]. Conclusion After infection of different numbers of E. multilocularismetacestode, the mice spleen NKT cells and their subsets changed significantly. The mice in the low and middle infection groups showed the immune response predominately with the CD4⁺ NKT17 type to kill and clear the parasites, while mice in the high infection group responded largely with the mixed subsets of CD4⁺ NKT17, NKT2 and NKT10 type cells, and NKT cells showed an inhibitory phenotype, leading to the decline of NKT1-type immune response, which is in favour of the parasite surviving.

Key words: Echinococcus multilocularis metacestode, Spleen, NKT cells, CD4⁺ NKT cell subset

CLC Number:

R383.33

LI Ling-hui, WANG Wei, HOU Xin-ling, SHI Yang, LI De-wei, LI Liang, WANG Hui, LI Jing, ZHANG Chuan-shan. Affects of Echinococcus multilocularis metacestode infection on the natural killer T cells and their subsets in mouse spleen[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2021, 39(3): 311-317.

Figures/Tables 2

Fig. 1

Table 1

Analysis of NKT cell subsets in the spleens of mice infected with different doses of E. multilocularis metacestode

细胞亚群	对照组	低感染组	中感染组	高感染组
NKT cell subsets	Control group	Low infection group	Middle infection group	High infection group
NKT (× 10⁵)	5.02 ± 1.08	4.90 ± 1.27	6.32 ± 0.53 ^b	7.37 ± 1.72 ^b
CD11b⁺ NKT (× 10⁵)	0.93 ± 0.18	0.95 ± 0.29	1.50 ± 0.25 ^b	1.45 ± 0.35 ^b
CD27⁺ NKT (× 10⁵)	4.35 ± 1.08	3.73 ± 0.99	5.44 ± 0.44	6.23 ± 1.92 ^a
NKT1 (IFN-γ)/%	17.30 ± 3.18	16.42 ± 2.82	13.93 ± 1.61 ^a	10.90 ± 3.04 ^b
NKT2 (IL-4)/%	4.37 ± 0.83	5.62 ± 0.58 ^a	5.86 ± 1.43 ^a	5.92 ± 0.94 ^a
NKT10 (IL-10)/%	4.86 ± 0.45	4.99 ± 1.30	5.53 ± 1.48	6.25 ± 2.16
NKT17 (IL-17A)/%	4.68 ± 0.73	7.02 ± 1.19 ^b	6.62 ± 0.41 ^b	3.73 ± 1.04 ^b
CD4⁺ NKT/%	30.03 ± 2.47	32.03 ± 3.07	24.75 ± 3.59 ^a	23.20 ± 4.82 ^b
CD4⁺ NKT (× 10⁵)	1.24 ± 0.26	1.37 ± 0.52	1.75 ± 0.36 ^a	1.82 ± 0.24 ^a
CD8⁺ NKT/%	26.08 ± 1.91	29.90 ± 2.14 ^a	31.60 ± 2.47 ^a	30.28 ± 3.69 ^a
CD8⁺ NKT (× 10⁵)	1.35 ± 0.31	1.56 ± 0.51	2.41 ± 0.42 ^b	2.25 ± 0.83 ^a
DN NKT/%	27.51 ± 3.88	24.76 ± 1.41	22.61 ± 2.85 ^a	32.76 ± 5.53 ^a
DN NKT (× 10⁵)	1.27 ± 0.36	1.20 ± 0.49	1.43 ± 0.19	2.15 ± 0.78 ^a
CD4⁺ NKT1 (IFN-γ)/ %	21.16 ± 2.83	16.00 ± 2.14 ^b	14.40 ± 1.81 ^b	12.5 ± 2.96 ^b
CD4⁺ NKT2 (IL-4)/%	10.49 ± 1.22	10.48 ± 1.47	9.90 ± 1.68	10.63 ± 1.79
CD4⁺ NKT10 (IL-10)/%	3.97 ± 0.89	4.63 ± 0.85	3.63 ± 1.15	4.79 ± 1.55
CD4⁺ NKT17 (IL-17A)/%	10.27 ± 1.79	16.73 ± 1.99 ^b	16.06 ± 1.42 ^b	14.41 ± 3.55 ^b
CD8⁺ NKT (IFN-γ)/%	15.83 ± 1.59	13.43 ± 0.92 ^a	10.04 ± 0.92 ^b	9.24 ± 1.37 ^b
CD8⁺ NKT (IL-10)/%	2.85 ± 0.64	3.43 ± 0.80	4.07 ± 0.48 ^b	3.92 ± 0.75 ^b
DN NKT (IFN-γ)/%	25.18 ± 5.78	20.31 ± 5.85	17.48 ± 2.50 ^a	14.06 ± 3.95 ^b
DN NKT (IL-10)/%	5.50 ± 0.79	5.30 ± 0.93	5.10 ± 0.93	5.71 ± 0.56

Table 1

References 20

[1]	Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: advances in the 21st century[J]. Clin Microbiol Rev, 2019,32(2):e00075-18.
[2]	Lachenmayer A, Gebbers D, Gottstein B, et al. Elevated incidence of alveolar echinococcosis in immunocompromised patients[J]. Food Waterborne Parasitol, 2019,16:e00060.
[3]	Wen H, Tuerganaili A, Shao YM, et al. Research achievements and challenges for echinococcosis control[J]. Chin J Parasitol Parasit Dis, 2015,33(6):466-471. (in Chinese)
[3]	( 温浩, 吐尔干艾力·阿吉, 邵英梅, 等. 棘球蚴病防治成就及面临的挑战[J]. 中国寄生虫学与寄生虫病杂志, 2015,33(6):466-471.)
[4]	Gottstein B, Wang J, Boubaker G, et al. Susceptibility versus resistance in alveolar echinococcosis (larval infection with Echinococcus multilocularis)[J]. Vet Parasitol, 2015,213(3/4):103-109.
[5]	Zhang C, Lin R, Li Z, et al. Immune exhaustion of T cells in alveolar echinococcosis patients and its reversal by blocking checkpoint receptor TIGIT in a murine model[J]. Hepatology, 2020,71(4):1297-1315.
[6]	Siddiqui S, Visvabharathy L, Wang CR. Role of group 1 CD1-restricted T cells in infectious disease[J]. Front Immunol, 2015,6:337.
[7]	Bandyopadhyay K, Marrero I, Kumar V. NKT cell subsets as key participants in liver physiology and pathology[J]. Cell Mol Immunol, 2016,13(3):337-346.
[8]	Liu Y, Cai YC, Chen SH, et al. Advances in research on the roles of natural killer T cells in immune responses to parasitic infections[J]. Chin J Parasitol Parasit Dis, 2020,38(4):477-481. (in Chinese)
[8]	( 刘毅, 蔡玉春, 陈韶红, 等. 自然杀伤T细胞在寄生虫感染免疫中作用的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2020,38(4):477-481.)
[9]	Zhang C, Shao Y, Yang S, et al. T-cell tolerance and exhaustion in the clearance of Echinococcus multilocularis: role of inoculum size in a quantitative hepatic experimental model[J]. Sci Rep, 2017,7(1):11153.
[10]	Kriegsmann K, Kriegsmann M, von Bergwelt-Baildon M, et al. NKT cells: new players in CAR cell immunotherapy?[J]. Eur J Haematol, 2018,101(6):750-757.
[11]	Robertson FC, Berzofsky JA, Terabe M. NKT cell networks in the regulation of tumor immunity[J]. Front Immunol, 2014,5:543.
[12]	Han Y, Jiang Z, Chen Z, et al. Pathogen-expanded CD11b⁺ invariant NKT cells feedback inhibit T cell proliferation via membrane-bound TGF-β1[J]. J Autoimmun, 2015,58:21-35.
[13]	Hammond KJL, Pelikan SB, Crowe NY, et al. NKT cells are phenotypically and functionally diverse[J]. Eur J Immunol, 1999,29(11):3768-3781.
[14]	Wei GJ, Tabel H. Regulatory T cells prevent control of experimental African trypanosomiasis[J]. J Immunol, 2008,180(4):2514-2521.
[15]	Antúnez MI, Cardoni RL. Trypanosoma cruzi: the expansion of NK, T, and NKT cells in the experimental infection[J]. Exp Parasitol, 2004,106(3/4):85-94.
[16]	Chuang YT, Leung K, Chang YJ, et al. A natural killer T-cell subset that protects against airway hyperreactivity[J]. J Allergy Clin Immunol, 2019,143(2):565-576.
[17]	Yang JQ, Zhou Y, Singh RR. Effects of invariant NKT cells on parasite infections and hygiene hypojournal[J]. J Immunol Res, 2016,2016:2395645.
[18]	Stange J, Hepworth MR, Rausch S, et al. IL-22 mediates host defense against an intestinal intracellular parasite in the absence of IFN-γ at the cost of Th17-driven immunopathology[J]. J Immunol, 2012,188(5):2410-2418.
[19]	Mallevaey T, Fontaine J, Breuilh L, et al. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis[J]. Infect Immun, 2007,75(5):2171-2180.
[20]	Zamora-Chimal J, Hernández-Ruiz J, Becker I. NKT cells in leishmaniasis[J]. Immunobiology, 2017,222(4):641-646.